See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $173B | 0.4x | 10.3x | |
| $24.7B | 6.7x | 28.0x | |
| $23.7B | n/a | n/a | |
| $16.9B | 1.7x | 26.9x | |
| $11.7B | 0.3x | 4.9x | |
| $9.7B | 2.0x | 30.6x | |
| $9.5B | 0.7x | 15.4x | |
| $9.2B | 1.1x | 13.5x | |
| $6.2B | 0.9x | 9.0x | |
| $4.7B | 1.6x | 11.4x | |
| $4.1B | 0.5x | 10.4x | |
| $4.1B | 0.5x | 7.4x | |
| $3.9B | 0.6x | 9.4x | |
| $3.8B | 0.6x | 8.6x | |
| $3.8B | 0.2x | 5.6x | |
| $3.5B | 1.3x | 7.8x | |
| $3.3B | 0.9x | 7.9x | |
| $3.3B | 0.9x | 13.1x | |
| $3.1B | 0.6x | 7.4x | |
| $2.8B | 0.7x | 6.5x | |
| $2.8B | 0.4x | 4.8x | |
| $2.1B | 0.8x | 10.4x | |
| $2.1B | 1.8x | 14.7x | |
| $2.0B | 0.6x | 6.5x | |
| $1.8B | n/a | n/a | |
| $1.7B | 0.5x | 22.9x | |
| $1.7B | 0.5x | 22.9x | |
| $1.7B | 0.9x | 7.2x | |
| $1.6B | 0.4x | 5.5x | |
| $1.4B | 0.5x | 8.6x | |
| $1.2B | 1.5x | 4.6x | |
| $1.2B | n/a | n/a | |
| $1.2B | n/a | n/a | |
| $1.2B | 1.6x | 18.8x | |
| $1.1B | 0.4x | n/a | |
| $1.1B | 0.8x | 10.6x | |
| $1.0B | 0.4x | 9.2x | |
| $961M | n/a | n/a | |
| $949M | 0.2x | 7.6x | |
| $743M | n/a | n/a | |
| $653M | n/a | n/a | |
| $584M | 1.0x | n/a | |
| $520M | 0.5x | 7.5x | |
| $468M | 0.3x | -8.0x | |
| $383M | n/a | n/a | |
| $345M | n/a | n/a | |
| $317M | n/a | n/a | |
| $270M | 0.1x | n/a | |
| $255M | 0.6x | 8.7x | |
| $252M | n/a | n/a | |
| $139M | n/a | n/a | |
| $124M | n/a | n/a | |
| $88.7M | n/a | n/a | |
| $85.3M | n/a | n/a | |
| $55.3M | n/a | n/a | |
| $24.3M | 0.4x | -92.4x | |
| $24.2M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies